26 Aug 2020 --- IFF Health and DolCas Biotech have partnered for the sale and marketing of Curcugen, dubbed as a “next-gen,” all-natural turmeric extract for supplements, food and beverages. Curcugen is positioned as a highly concentrated and highly dispersible curcumin ingredient with “superior functionality,” recently backed by a human study. The new partnership will enable IFF Health, part of International Flavors & Fragrances (IFF), to expand its activities into the market for curcumin nutraceuticals.
